⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KALV News
KalVista Pharmaceuticals, Inc. Common Stock
KalVista Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of KalVista Pharmaceuticals, Inc. - KALV
businesswire.com
KALV
Are KALV, TBRG, UNF, ESQ Obtaining Fair Deals for their Shareholders?
prnewswire.com
KALV
UNF
TBRG
ESQ
Shareholder Alert: Ademi LLP investigates whether KalVista Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders
prnewswire.com
KALV
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of KalVista Pharmaceuticals, Inc. (NASDAQ: KALV)
globenewswire.com
KALV
KALV Stock Alert: Halper Sadeh LLC is Investigating Whether KalVista Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders
businesswire.com
KALV
Form 8-K
sec.gov
KALV
Il Gruppo Chiesi acquisisce KalVista Pharmaceuticals, rafforzando il portafoglio globale nelle Malattie Rare
businesswire.com
KALV
Chiesi Group to Acquire KalVista Pharmaceuticals, Expanding its Global Rare Disease Portfolio
businesswire.com
KALV
Form 8-K
sec.gov
ACOG
BIIB
SUPN
KALV
KalVista Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference
businesswire.com
KALV